CD4+ and CD8+ cellular responses were quite similar between all subgroups of hypogammaglobulinemia, and CVID patients have almost equally strong cell-mediated immune responses compared to immunocompetent HCWs (4). This evidence concerns the gene CD8A and agammaglobulinemia.